 |
인쇄하기
취소
|
Ilyang to conduct Phase 3 study on new leukemia drug
Ilyang Pharmaceutical Co. says it will carry out its Phase III clinical trial for a new leukemia medicine IY5511.
The study is to be conducted for 250 leukemia patients in the chronic and accelerated phases of the disease for 12 months. Nine domestic hospitals and other foreign ones ― in Indonesia, India and Thailand ― will join the trial.
The drug is believed to be 30 times more effectiv...
The study is to be conducted for 250 leukemia patients in the chronic and accelerated phases of the disease for 12 months. Nine domestic hospitals and other foreign ones ― in Indonesia, India and Thailand ― will join the trial.
The drug is believed to be 30 times more effectiv...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.